These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 1668012)

  • 1. Hypercholesterolaemia alters platelet reactivity and the antihypertensive effect of nitrendipine.
    Le Quan Sang KH; Mazeaud M; Levenson J; Del Pino M; Pithois-Merli I; Simon A; Devynck MA
    J Hypertens Suppl; 1991 Dec; 9(6):S410-1. PubMed ID: 1668012
    [No Abstract]   [Full Text] [Related]  

  • 2. Hypercholesterolemia modulates the effects of nitrendipine on blood pressure and platelet function in essential hypertension.
    Mazeaud MM; Sang KH; Astarie C; Levenson J; Simon A; Devynck MA
    J Cardiovasc Pharmacol; 1991; 18 Suppl 10():S46-51. PubMed ID: 1725003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma lipids and platelet membrane fluidity in essential hypertension.
    Le Quan Sang KH; Mazeaud M; Astarie C; Duranthon V; Driss F; Devynck MA
    Thromb Haemost; 1993 Jan; 69(1):70-6. PubMed ID: 8383361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotonin metabolism and platelet aggregation under antihypertensive treatment with nitrendipine.
    Sebeková K; Raucinová M; Sedláková K; Dzúrik R
    J Cardiovasc Pharmacol; 1988; 12 Suppl 4():S161-3. PubMed ID: 2468865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased platelet cholesterol and decreased percentage volume of platelets as a secondary risk factor for coronary artery disease.
    Ravindran R; Krishnan LK
    Pathophysiol Haemost Thromb; 2007; 36(1):45-51. PubMed ID: 18332614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical and functional alterations associated with hypercholesterolemia in platelets from hypertensive patients.
    Mazeaud MM; Driss F; Le Quan Sang KH; Duranthon V; Levenson J; Simon A; Devynck MA
    Atherosclerosis; 1992 Jun; 94(2-3):201-11. PubMed ID: 1321632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of hypertension with dihydropyridine calcium antagonists and aspirin.
    Tison P; Ulicna L; Jakubovska Z; Oravcova J; Fetkovska N
    Blood Press Suppl; 1994; 1():57-60. PubMed ID: 8205303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet membrane fluidity and platelet membrane lipid pattern in essential hypertension.
    Caimi G; Lo Presti R; Montana M; Contorno A; Canino B; Catania A; Sarno A; Cerasola G
    Am J Hypertens; 1995 Jan; 8(1):82-6. PubMed ID: 7734103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of long-acting propranolol and verapamil on blood pressure, platelet function, metabolic and rheological properties in hypertension.
    Ding YA; Chou TC; Lin KC
    J Hum Hypertens; 1994 Apr; 8(4):273-8. PubMed ID: 8021907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of lotensin and nitrendipine on plasma fibrinogen and platelet aggregation in hypertensive patients].
    Pan R; Sun M; Zhou H; Jia Z
    Hunan Yi Ke Da Xue Xue Bao; 1998; 23(1):87-9. PubMed ID: 10681808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet aggregation and in vivo shear forces.
    Mazeaud MM; Levenson J; Le Quan Sang KH; Simon A; Devynck MA
    Thromb Haemost; 1994 Jan; 71(1):26-31. PubMed ID: 8165643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blunted inhibition by insulin of agonist-stimulated calcium, pH and aggregatory responses in platelets from hypertensive patients.
    Touyz RM; Schiffrin EL
    J Hypertens; 1994 Nov; 12(11):1255-63. PubMed ID: 7868873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of dihydropyridines and their combination with aspirin on blood pressure and circadian platelet activity in patients with essential hypertension.
    Tison P; Ulicna L; Jakubovska Z; Oravcova J; Fetkovska N
    Am J Hypertens; 1994 Jul; 7(7 Pt 2):46S-49S. PubMed ID: 7946179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effect of long-term therapy with a calcium antagonist on thrombocyte function in hypertension patients].
    Baliakina EV; Atakhanov ShE; Gabbasov ZA; Popov EG; Iurenev AP
    Ter Arkh; 1992; 64(8):39-43. PubMed ID: 1440393
    [No Abstract]   [Full Text] [Related]  

  • 15. Nitrendipine efficacy and safety in patients with mild and moderate essential hypertension.
    Di Salvo MM; Finocchiaro PM; Bonaccorso M; Attanasio L
    J Cardiovasc Pharmacol; 1991; 18 Suppl 1():S45-7. PubMed ID: 1723454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of the chronic antihypertensive effect of nitrendipine using ambulatory monitoring].
    Rossi L; Tomei R; Carbonieri E; Franceschini L; Zardini P
    Cardiologia; 1994 Mar; 39(3):187-91. PubMed ID: 8039197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of nitrendipine in mild or moderate essential hypertensive subjects with type II diabetes.
    Papalia D; Casale P
    J Cardiovasc Pharmacol; 1991; 18 Suppl 1():S98-100. PubMed ID: 1723469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deuterium oxide normalizes blood pressure and elevated cytosolic calcium in rats with ethanol-induced hypertension.
    Vasdev S; Gupta IP; Sampson CA; Longerich L; Parai S
    Can J Cardiol; 1993 Nov; 9(9):802-8. PubMed ID: 8281480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of therapy with diuretics on the functional activity of platelets in patients with arterial hypertension and abdominal obesity].
    Simonenko VB; Medvedev IN; Briukhovetskiĭ AG
    Klin Med (Mosk); 2012; 90(11):54-6. PubMed ID: 23516856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of calcium on blood pressure, platelet aggregation and erythrocyte sodium transport in Dahl salt-sensitive rats.
    Kang JS; Cregor MD; Smith JB
    J Hypertens; 1990 Mar; 8(3):245-50. PubMed ID: 2159505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.